Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Science Translational Medicine
|
February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma
Laura D Gamble, Stefania Purgato, Jayne Murray, et al.
Cancer Research
|
July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
Chelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2021
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Lin Xiao, Klaartje Somers, Jayne Murray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Cell Death & Disease
|
March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors
Christoph Grohmann, Francesca Walker, Mark Devlin, et al.
Nature Communications
|
June 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity
Isabel Soria-Bretones, Matias Casás-Selves, Minu Samanta, et al.
Nature Communications
|
July 11, 2024
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis
Jayne E Murray, Emanuele Valli, Giorgio Milazzo, et al.
EMBO Molecular Medicine
|
December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer
Loretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Cancer Cell
|
March 31, 2023
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Claire Xin Sun, Paul Daniel, Gabrielle Bradshaw, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Science Translational Medicine
|
February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma
Laura D Gamble, Stefania Purgato, Jayne Murray, et al.
Cancer Research
|
July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
Chelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2021
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Lin Xiao, Klaartje Somers, Jayne Murray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Cell Death & Disease
|
March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors
Christoph Grohmann, Francesca Walker, Mark Devlin, et al.
Nature Communications
|
June 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity
Isabel Soria-Bretones, Matias Casás-Selves, Minu Samanta, et al.
Nature Communications
|
July 11, 2024
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis
Jayne E Murray, Emanuele Valli, Giorgio Milazzo, et al.
EMBO Molecular Medicine
|
December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer
Loretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Cancer Cell
|
March 31, 2023
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Claire Xin Sun, Paul Daniel, Gabrielle Bradshaw, et al.
Page
of 6